Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

Citation
Patorno E, Schneeweiss S, Gopalakrishnan C, et al. Diabetes Care 2019;42:2204–10.